Market Cap: $1.56B
Market Cap: $1.56B
Open
$22.99
Prev. Close
$27.92
High
$24.99
Low
$22.99
Enovis Corporation is a global medical technology enterprise specializing in the design, production, and supply of medical devices. These specialized products are instrumental for a diverse range of healthcare professionals—including orthopedic specialists, surgeons, general physicians, pain management experts, physical therapists, podiatrists, chiropractors, and athletic trainers—who treat patients with musculoskeletal conditions resulting from degenerative illnesses, deformities, traumatic events, or sports-related injuries.
Enovis Corporation trades on the New York Stock Exchange under the ticker ENOV, priced in USD.
Enovis Corporation has a market capitalisation of $1.56B, based on its latest share price.
ENOV has no meaningful P/E ratio because it reported a loss over the last 12 months.
Over the past 52 weeks ENOV has traded between $16.70 and $31.67.
No. Enovis Corporation does not currently pay a dividend.
Loss-making over the last 12 months (net margin -22.9%).
The analyst consensus rating for ENOV is Buy. Analysts' average 12-month price target of $39.94 implies 47% upside.
Damien McDonald is the CEO of Enovis Corporation, which is headquartered in Lewisville.
Generated automatically from reported financial data. General information only, not financial advice.

Enovis (Ticker: ENOV) demonstrates robust growth in its latest financial report, showcasing a 84.34% increase in net profit year-over-year. The company recorded quarterly revenues of USD 589.15 millio…
Enovis: Pioneering Innovations in Health Solutions Enovis emphasizes its commitment to innovation within the health sector as it navigates a rapidly evolving market. Health companies like MediHealth a…
Enovis Anticipates Growth in Innovative Health Solutions Amid Industry Developments Enovis, a prominent player in the health technology sector, stands at the forefront of a transformation fueled by ad…
Enovis Focuses on Advancements in Healthcare Solutions Amid Market Anticipations As the corporate world shifts its attention towards upcoming earnings reports, Enovis continues to make strides in the…